Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 86,000 | -237,000 | 578,000 | 608,000 | 219,000 |
| Depreciation Amortization | 369,000 | 316,000 | 300,000 | 326,000 | 329,000 |
| Income taxes - deferred | -27,000 | -158,000 | 20,000 | -77,000 | -120,000 |
| Accounts receivable | -152,000 | -10,000 | 91,000 | -225,000 | 175,000 |
| Accounts payable and accrued liabilities | -9,000 | -72,000 | 105,000 | 281,000 | 55,000 |
| Other Working Capital | -1,052,000 | 620,000 | -103,000 | 13,000 | 356,000 |
| Other Operating Activity | 152,000 | 97,000 | -236,000 | -112,000 | -207,000 |
| Operating Cash Flow | $-633,000 | $556,000 | $755,000 | $814,000 | $807,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -357,000 | -227,000 | -274,000 | -277,000 | -267,000 |
| Net Acquisitions | N/A | N/A | N/A | 508,000 | 5,000 |
| Other Investing Activity | 4,000 | -2,000 | -10,000 | -11,000 | 28,000 |
| Investing Cash Flow | $-353,000 | $-229,000 | $-284,000 | $220,000 | $-234,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 12,000 |
| Debt Issued | 699,000 | 771,000 | 105,000 | 741,000 | 1,100,000 |
| Debt Repayment | -604,000 | -378,000 | -185,000 | -967,000 | -1,265,000 |
| Common Stock Issued | 9,000 | 19,000 | 51,000 | 23,000 | 16,000 |
| Common Stock Repurchased | N/A | -69,000 | -495,000 | -173,000 | N/A |
| Dividend Paid | -148,000 | -149,000 | -154,000 | -164,000 | -164,000 |
| Other Financing Activity | 8,000 | -22,000 | -8,000 | -14,000 | -148,000 |
| Financing Cash Flow | $-36,000 | $172,000 | $-686,000 | $-554,000 | $-449,000 |
| Exchange Rate Effect | -22,000 | 4,000 | -32,000 | -34,000 | 38,000 |
| Beginning Cash Position | 1,807,000 | 1,304,000 | 1,551,000 | 1,105,000 | 943,000 |
| End Cash Position | 763,000 | 1,807,000 | 1,304,000 | 1,551,000 | 1,105,000 |
| Net Cash Flow | $-1,044,000 | $503,000 | $-247,000 | $446,000 | $162,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -633,000 | 556,000 | 755,000 | 814,000 | 807,000 |
| Capital Expenditure | -360,000 | -370,000 | -307,000 | -277,000 | -267,000 |
| Free Cash Flow | -993,000 | 186,000 | 448,000 | 537,000 | 540,000 |